Hardy Diagnostics

HARDY DIAGNOSTICS MAKES GENEROUS DONATION TO A LOCAL HOSPITAL FOR SPECIALIZED LABORATORY EQUIPMENT

Retrieved on: 
Tuesday, January 9, 2024
Laboratory, Hospital, Central Coast, MD, Medical director, Hardy Diagnostics, Pathology, Microbiology, Bacteria, Disease, FDA, Organization, Fungus, Diagnosis, Medical device

SANTA MARIA, Calif., Jan. 9, 2024 /PRNewswire/ -- Microbiology device manufacturer Hardy Diagnostics, made a generous donation to the Marian Regional Medical Center Foundation to support the purchase of advanced identification equipment in the hospital's laboratory. The donation of $289,000 has allowed the lab to purchase highly specialized bacteria and fungi identification equipment not previously available on the Central Coast of California. The equipment will play a vital role in the rapid diagnosis of disease.

Key Points: 
  • SANTA MARIA, Calif., Jan. 9, 2024 /PRNewswire/ -- Microbiology device manufacturer Hardy Diagnostics, made a generous donation to the Marian Regional Medical Center Foundation to support the purchase of advanced identification equipment in the hospital's laboratory.
  • The donation of $289,000 has allowed the lab to purchase highly specialized bacteria and fungi identification equipment not previously available on the Central Coast of California.
  • Donation allows local lab to purchase highly specialized bacteria and fungi identification equipment.
  • Following the ceremony, Jay Hardy and Andre Hsiung, Hardy's Chief Scientific Officer, spoke to the laboratory personnel about Hardy Diagnostics' humble beginnings and its rich history of helping people live healthier lives since 1980.

Hardy Diagnostics awarded Manual Microbiology agreement with Premier, Inc.

Retrieved on: 
Tuesday, February 28, 2023
Premier, Inc., Learning, Trust, Culture, Hardy Diagnostics, Diagnosis, Hardy, Microbiology, Disease, Hospital, Partnership, Marketing, Business, Chromogen, Clinical collaboration, Medical device

SANTA MARIA, Calif. , Feb. 28, 2023 /PRNewswire/ -- Hardy Diagnostics has been awarded a national group purchasing agreement for Manual Microbiology with Premier, Inc.

Key Points: 
  • SANTA MARIA, Calif. , Feb. 28, 2023 /PRNewswire/ -- Hardy Diagnostics has been awarded a national group purchasing agreement for Manual Microbiology with Premier, Inc.
  • Effective 2/1/23, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Microbiology products.
  • Hardy Diagnostics awarded national group purchasing agreement for manual microbiology with Premier, Inc.
    "We are so excited and proud to be part of the Premier network and look forward to sharing our story and learning how we can best support Premier members.
  • All Hardy Diagnostics' products offered are aimed at providing clinical laboratories across the country with tools for the detection and diagnosis of disease.

CompactDry TCR (Total Count Rapid) is added to the Hardy Diagnostics' Product Offering

Retrieved on: 
Tuesday, February 7, 2023
AOAC, Medium (website), Food industry, Safety, Food, Hardy Diagnostics, PTM, Diagnosis, Wizard, FDA, Multimedia, HACCP, Cosmetics, Microbiology, Online shopping, Medical device

SANTA MARIA, Calif., Feb. 7, 2023 /PRNewswire/ -- Hardy Diagnostics proudly announces the launch of CompactDry TCR, a ready-to-use dehydrated culture medium plate for the detection and enumeration of microorganisms that provides total aerobic plate counts in as little as 24 hours. This self-diffusing plate is AOAC PTM-certified and is the easiest way to perform plate counts, requiring no spreading or stamping. Simply remove the lid, dispense 1mL of sample onto the center of the plate, place the lid, and incubate. Dye indicators in the medium allow colonies to be easily and reliably read from center to edge. Plates are securely stackable, and the innovative design eliminates the possibility of sample leakage - saving time, increasing safety, and allowing for unobstructed growth and ease of colony picking.

Key Points: 
  • This self-diffusing plate is AOAC PTM-certified and is the easiest way to perform plate counts, requiring no spreading or stamping.
  • Simply remove the lid, dispense 1mL of sample onto the center of the plate, place the lid, and incubate.
  • With its rapid results and ease of use, CompactDry TCR will be an indispensable tool to facilities and labs throughout the food industry.
  • Hardy Diagnostics is an FDA-licensed manufacturer of medical devices for microbiological testing with an ISO 13485 certified Quality Management System.

Food Testing, Inspection and Certification Market Global Opportunities and Competitive Landscape Report 2022 Featuring Hardy Diagnostics, Intertek Group, Promega and R-Biopharm - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 6, 2022
Technology, Food Tech, Pressure, Competitive landscape, Risk, Food, FSMA, Growth, Certification, Salmonella, Genetically modified organism, Oil, CAGR, Quality control, Intertek, TIC, Campylobacter, Food industry, Pesticide, BCC, Milk, Technology, Organization, Hardy Diagnostics, Life Technologies Corp. v. Promega Corp., Industry, Ill, Food safety, Awareness, Incidence, Toxicity, Research, Safety, Inspection, Food quality, Environment, COVID-19, Compliance, Medical device, Retail, Dietary supplement, Listeria

The "Food Testing, Inspection and Certification Market: Global Market Opportunities and Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Food Testing, Inspection and Certification Market: Global Market Opportunities and Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.
  • This report provides market insights into the food testing, inspection and certification market, specifically focusing on the global markets.
  • The global food testing, inspecting and certification market is expanding, and it has significant growth potential during the forecast period.
  • The passage of the U.S. Food Safety Modernization Act (FSMA) heralds a growth in the global market for food safety testing.

Global Viral Transport Medium Market Report 2022-2027 Featuring Key Vendors - BD, Hardy DX, HiMedia Labs, Laboratory Corp of America, Puritan Medical Products, Thermo Fisher Scientific, & Vircell - ResearchAndMarkets.com

Retrieved on: 
Monday, August 8, 2022
Health, Infectious Diseases, FDA, Antibody, Herpes labialis, Mortality, Simplex, Diagnosis, Population, Growth, Chickenpox, RSV, SARS-COV-2, Hardy Diagnostics, Hospital, Prevalence, Research, Respiratory syncytial virus, Patient, Viral disease, Degenerative disease, COVID-19, Infection, Vaccine, Ageing, Transport, Nature, Enterovirus, Disease, Maintenance, PLOS, Solution, VTM, Collection, Pharmacy, Thermo Fisher Scientific, Animal, Pharmaceutical industry

More recently, the sudden onset of the COVID-19 pandemic significantly changed the demand for transport medium products and related kits.

Key Points: 
  • More recently, the sudden onset of the COVID-19 pandemic significantly changed the demand for transport medium products and related kits.
  • Owing to the surge in demand for diagnostic tests and sample collection from people, many vendors increased their production.
  • Most of the leading and emerging companies took part in fulfilling VTM supply across the healthcare system in the world.
  • The global viral transport medium market is highly competitive in nature due to the presence of domestic, regional, and international market players.

Applied BioCode Announces Exclusive Partner Distribution Agreement with Hardy Diagnostics, Further Broadens Reach of BioCode® MDx-3000 System into Hospitals and Reference Laboratories in the United States

Retrieved on: 
Monday, March 14, 2022
Manufacturing, Women, Men, Consumer, Other Travel, Other Communications, Travel, Marketing, Small Business, Communications, Other Automotive, Telecommunications, Software, Internet, Science, Finance, Data Management, Consumer Electronics, Banking, Automotive, Technology, Accounting, Professional Services, Vacation, Mining, Minerals, Semiconductor, Agriculture, Natural Resources, Utilities, Research, Other Manufacturing, Nanotechnology, Audio, Video, Energy, Engineering, Chemicals, Plastics, Federal Food, Drug, and Cosmetic Act, Virus, Laboratory, Hardy, Company, Analyte-specific reagent, Hardy Diagnostics, Allergy, FDA, RSV, EUA, RPP, LDT, Infection, CE marking, GPP, Respiratory tract, ASRS, Hospital, Nomenclature codes, Immunochemistry, IVD, Applied Spectral Imaging, Emergency Use Authorization, Hair, BMB, Autoimmune disease, COVID-19, Microbiology, Molecular Probes, Severe acute respiratory syndrome coronavirus 2, Medical degree, Diagnosis, Medical device, Vaccine

Under the terms of the exclusive agreement, Hardy Diagnostics will begin offering the MDx-3000 System to clinical laboratory customers in the United States.

Key Points: 
  • Under the terms of the exclusive agreement, Hardy Diagnostics will begin offering the MDx-3000 System to clinical laboratory customers in the United States.
  • Applied BioCode is thrilled to partner with Hardy Diagnostics, and we look forward to working closely with the Hardy team to expand our reach to hospitals and reference laboratories in the US, said Winston Ho, President of Applied BioCode.
  • Jay Hardy, Chief Executive Officer of Hardy Diagnostics, said, "We are very excited to add the Applied BioCode MDx-3000 molecular platform to our lineup of instruments to streamline the processes for microbiologists."
  • Hardy adds, "Our Company prides itself on offering our laboratory partners innovative solutions to detect and diagnose disease.

Hardy Diagnostics Now Offers the BioCode® MDx-3000

Retrieved on: 
Monday, March 14, 2022
Federal Food, Drug, and Cosmetic Act, Gram, Partnership, NL63, Laboratory, RPP, OC43, STEC, Campylobacter, Hair, BMB, Emergency Use Authorization, Severe acute respiratory syndrome coronavirus 2, Bacteria, Stanford University v. Roche Molecular Systems, Inc., Hardy, Escherichia coli, Hardy Diagnostics, Allergy, FDA, EIEC, EUA, Infection, EAEC, GLOBE, Hematology, Autoimmune disease, LIS, Microbiology, ETEC, PCR, Automation, 1993 Jack in the Box E. coli outbreak, RSV, Vibrio parahaemolyticus, Culture, GPP, Immunochemistry, Nomenclature codes, IVD, Fungus, Medical degree, Molecular Probes, Yersinia enterocolitica, Virus, COVID, HKU1, Laboratory information management system, CE marking, Hospital, Technology, COVID-19, Diagnosis, Vaccine, Medical device, Coronavirus

"Applied BioCode is thrilled to partner with Hardy Diagnostics," said Winston Ho, President of Applied BioCode.

Key Points: 
  • "Applied BioCode is thrilled to partner with Hardy Diagnostics," said Winston Ho, President of Applied BioCode.
  • "We look forward to working with the Hardy Diagnostics team to expand our reach in hospitals and reference laboratories in the US."
  • Hardy Diagnostics is an FDA-licensed manufacturer of medical devices for microbiology testing with an ISO 13485 certified Quality Management System.
  • Hardy Diagnostics distributes more than 13,000 products, services more than 10,000 laboratories and exports to more than 80 foreign distributors.

New Settle Plate Stands for Environmental Monitoring of Pharmaceutical Cleanrooms

Retrieved on: 
Wednesday, January 26, 2022
Microbiology, Stainless steel, AISI, Hardy Diagnostics, Catalog, Solution, Agar, GLOBE, AISI 316, FDA, Medical device

SANTA MARIA, Calif., Jan. 26, 2022 (GLOBE NEWSWIRE) -- Hardy Diagnostics announces new TRIO.SETTLE stands, specially designed for passive microbial air monitoring.

Key Points: 
  • SANTA MARIA, Calif., Jan. 26, 2022 (GLOBE NEWSWIRE) -- Hardy Diagnostics announces new TRIO.SETTLE stands, specially designed for passive microbial air monitoring.
  • Hardy Diagnostics is an ISO 13485 certified, FDA licensed manufacturer, providing solutions to support microbiology testing and regulatory compliance requirements.
  • TRIO.SETTLE stands, fabricated with AISI 316 stainless steel, are available in floor and table formats.
  • They accommodate an open culture plate and lid to provide a standardized and aseptic sampling process, mitigating contamination during sampling.

Hardy Diagnostics Releases HardyCHROM™ Candida + auris

Retrieved on: 
Wednesday, October 20, 2021
Rossato, Hardy Diagnostics, Disease, Auris, Candida auris, Skin, GLOBE, MDR, Mortality, UV, Medical device

SANTA MARIA, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Hardy Diagnostics is pleased to announce its release of HardyCHROM Candida + auris , a chromogenic media recommended for the selective isolation and differential identification of Candida species.

Key Points: 
  • SANTA MARIA, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Hardy Diagnostics is pleased to announce its release of HardyCHROM Candida + auris , a chromogenic media recommended for the selective isolation and differential identification of Candida species.
  • Colonies of C. auris will appear white with a characteristic teal to teal-green "bullseye" center.
  • Additionally, C. auris is also differentiated from other Candida species by a unique fluorogenic reaction under UV light.
  • (1)
    HardyCHROM Candida + auris can be used in conjunctions with Rapid Trehalose Broth or GlabrataQuick to aid in the identification of C. glabrata.

Hardy Diagnostics Presents: Detection of Carbapenemase Producing Organisms; Advancements and Barriers to the Clinical Laboratory

Retrieved on: 
Tuesday, September 21, 2021
CRE, LFS, Molecular diagnostics, Medical college, Partnership, Medical College of Wisconsin, American Society for Microbiology, Froedtert Hospital, CST, Medical director, Patient, Bacteria, Journal of Clinical Microbiology, Family, Hardy Diagnostics, Journal, Pathology, AAM, Doctor of Philosophy, Society, GLOBE, Medical device, Medical imaging

Some bacteria in this family are resistant to nearly all antibiotics, leaving only more toxic or less effective treatment options.

Key Points: 
  • Some bacteria in this family are resistant to nearly all antibiotics, leaving only more toxic or less effective treatment options.
  • To learn more about the utility of screening for Carbapenem-resistant Enterobacterales and the technologies that are available to do so, Hardy Diagnostics is pleased to offer a free webinar titled, "Detection of carbapenemase-producing organisms; advancements and barriers to the clinical lab," on Oct.7, 2021, at 11 a.m. PST/1 p.m. CST.
  • Led by Nathan Ledeboer, PhD, D(ABMM), F(AAM) this discussion will:
    Discuss the utility of screening for CRE from clinical specimens.
  • To learn more about the products offered at Hardy Diagnostics to detect and diagnose disease, please visit www.hardydiagnostics.com .